“Zanolimumab (HuMax-CD4®), a Fully Human Monoclonal Antibody in Clinical Development for Cutaneous T-Cell Lymphoma”. 2009. Hematology Meeting Reports (formerly Haematologica Reports) 2 (5). https://doi.org/10.4081/hmr.v2i5.736.